Publicaciones en colaboración con investigadores/as de Montreal Heart Institute (17)

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication

    Heart Rhythm, Vol. 14, Núm. 1, pp. e3-e40

2016

  1. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication

    Journal of Arrhythmia, Vol. 32, Núm. 4, pp. 247-278

  2. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication

    Europace, Vol. 18, Núm. 10, pp. 1455-1490

2015

  1. The value of core lab stress echocardiography interpretations: Observations from the ISCHEMIA Trial

    Cardiovascular Ultrasound, Vol. 13, Núm. 1

2014

  1. Atrial fibrillation ablation: Translating basic mechanistic insights to the patient

    Journal of the American College of Cardiology, Vol. 64, Núm. 8, pp. 823-831

2011

  1. Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: A clinical-experimental correlation

    Heart Rhythm, Vol. 8, Núm. 9, pp. 1426-1433

2010

  1. Cardiac Anatomy for Catheter Mapping and Ablation of Arrhythmias

    Catheter Ablation of Cardiac Arrhythmias: Expert Consult - Online and Print (Elsevier), pp. 74-102

  2. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study

    Archives of Cardiovascular Diseases, Vol. 103, Núm. 3, pp. 160-169

  3. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins

    Circulation, Vol. 121, Núm. 8, pp. 963-972

2008

  1. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design

    Archives of Cardiovascular Diseases, Vol. 101, Núm. 6, pp. 399-406

1992

  1. Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 262, Núm. 1 31-1

  2. Selective inhibition of the contractile apparatus: A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion

    Circulation, Vol. 85, Núm. 3, pp. 1160-1174

1991

  1. Role of oxygen restoration in reperfusion-induced arrhythmias: Differential effects on ventricular ectopic activity and ventricular fibrillation in the pig

    Journal of Applied Cardiology, Vol. 6, Núm. 6, pp. 411-420

1990

  1. Determinants of hemorrhagic infarcts: Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion

    American Journal of Pathology, Vol. 137, Núm. 2, pp. 301-311

  2. Intracoronary infusion of superoxide dismutase and reperfusion injury in the pig heart

    Basic Research in Cardiology, Vol. 85, Núm. 6, pp. 619-629

1988

  1. Influence of tachycardia and arterial hypertension on infarct size in the pig

    Cardiovascular Research, Vol. 22, Núm. 9, pp. 620-626